Intranasal Remimazolam for Premedication in Pediatric Patient

Sponsor
Second Affiliated Hospital of Wenzhou Medical University (Other)
Overall Status
Recruiting
CT.gov ID
NCT04720963
Collaborator
(none)
90
1
3
17.7
5.1

Study Details

Study Description

Brief Summary

Anesthetic inhalation induction could be one of the most stressful experiences for children during the perioperative period, with almost 50% of them showing anxiety. It is an essential challenge for pediatric anesthesiologists on how to decrease anxiety for children in the operating room (OR) environment and to facilitate a smooth induction of anesthesia. Various factors like parental separation, unfamiliar surroundings, fear of physicians and needle injections can increase their preoperative anxiety. The researchers conducted the current study to investigate whether intranasal remimazolam can reduce anxiety in children before surgery.

Condition or Disease Intervention/Treatment Phase
Phase 4

Detailed Description

children aged 2-5 years old were randomly allocated into three equal groups based on the premedication routes: Group R with intranasal remimazolam, Group D with intranasal dexmedetomidine and Group P with intranasal placebo, respectively.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
90 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Intranasal Remimazolam for Premedication in Pediatric Patients: a Double-blinded Randomized Clinical Trial
Actual Study Start Date :
Feb 7, 2021
Anticipated Primary Completion Date :
Aug 1, 2022
Anticipated Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Placebo Comparator: group P (Placebo group)

intranasal placebo 20-30min before anesthesia induction

Other: Distilled water for injection
intranasal distilled water for injection

Experimental: group R (remimazolam group)

intranasal remimazolam 20-30min before anesthesia induction

Drug: Remimazolam
intranasal remimazolam

Active Comparator: group D (Dexmedetomine group)

intranasal dexmedetomidine 20-30min before anesthesia induction

Drug: Dexmedetomidine
Intranasal dexmedetomidine

Outcome Measures

Primary Outcome Measures

  1. The level of anxiety [up to 20 minutes after study drug given]

    The Modified Yale Preoperative Anxiety Scale: The 22-item measure has five behavioural categories: activity, emotional expressivity, alertness and arousal, vocalizations, and interaction with parents. Total scores range from 23.33 through 100 with higher scores indicating greater anxiety.

Secondary Outcome Measures

  1. The level of sedation [up to 20 minutes after study drug given]

    The modified observer's assessment of alert /sedation 0 = does not respond to deep stimulus; = does not respond to mild prodding or shaking; = responds only after mild prodding or shaking; = responds only after name is called loudly or repeatedly; = lethargic response to name spoken in normal tone; = responds readily to name spoken in normal tone. higher scores mean a higher levels of sedation.

  2. The onset time of satisfactory sedation [up to 20 minutes after study drug given]

    The onset time of satisfactory sedation, defined as the time from drug administration to the time when the modified observer's assessment of alert /sedation reached 2 point. 0 = does not respond to deep stimulus; = does not respond to mild prodding or shaking; = responds only after mild prodding or shaking; = responds only after name is called loudly or repeatedly; = lethargic response to name spoken in normal tone; = responds readily to name spoken in normal tone.higher scores mean a higher levels of sedation.

  3. the compliance of study drug given [up to 20 minutes before anesthesia induction]

    behavior score Clam and cooperative; Anxious but reassurable; Anxious but not reassurable; Crying, or resisting The scores of 1 and 2 signified satisfactory compliance, whereas scores of 3 and 4 were classified as poor compliance.

  4. Parental separation anxiety scale [up to 20 minutes after study drug given]

    A four-point parental separation anxiety scale as follows: Easy separation, Whimpers, but is easily reassured, not clinging, Cries and cannot be easily reassured, but not clinging to parents, Crying and clinging to parents. The scores of 1 and 2 signified acceptable separation whereas scores of 3 and 4 were classified as difficult separation.

  5. The degree of cooperation during inhalation anesthesia induction [intraoperative, (During inhalation anesthesia induction)]

    Induction Compliance Checklist range from 0 through 10,and lower scores indicate the higher degree of cooperation during inhalation anesthesia induction

  6. Mask acceptance scale,MAS [intraoperative, (During inhalation anesthesia induction)]

    Mask acceptance scale,MAS terrified, crying, agitated moderate fear, not calmed with reassurance slight fear of mask, easily calmed unafraid, cooperative, accepts mask readily The scores of 3 and 4 signified satisfactory mask acceptable whereas scores of 1 and 2 were classified as poor mask acceptable.

  7. Pediatric anesthesia emergence delirium scale,PAEDs [Within up to 15-30 minutes after child's first eye opening in the postoperative period]

    The pediatric anesthesia emergence delirium scale consists of four items. Each item is scored 0-4 yielding a total between 0 and 20. The degree of emergence delirium increased directly with the total score.pediatric anesthesia emergence delirium scale ≥12 at any time indicates presence of emergence delirium.

  8. Recovery times [Within up to 30 minutes after child's first eye opening in the postoperative period]

    The time from discontinuation of sevoflurane to the first open eye of the children and to achieve aldrete≥9

  9. Number of children with adverse effects [Up to 24 hours including preoperative, intraoperative, and postoperative periods]

    Number of children with adverse effects Bradycardia and/or hypotension need for hemodynamic support Desaturation is defined as Oxygen desaturation <90% Any adverse effects requiring interventions

Eligibility Criteria

Criteria

Ages Eligible for Study:
2 Years to 5 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. with American Society of Anesthesiologists (ASA) physical status I or II;

  2. aged 2-5 years;

  3. children with weight for age within the normal range

  4. were scheduled surgery with general anesthesia

Exclusion Criteria:
  1. Children who had gastrointestinal,Cardiovascular or endocrine dysfunction;

  2. contraindication to preoperative sedation or had a known allergy or hypersensitive reaction to either dexmedetomidine or remimazolam;

  3. with any nasal pathology,organ dysfunction;

  4. recently respiratory infection, mental disorder;

  5. other reasons that researchers hold it is not appropriate to participate in this trial.-

Contacts and Locations

Locations

Site City State Country Postal Code
1 The second Affiliated Hospital and Yuying Children's Hospital of Wenzhou Medical University Wenzhou Zhejiang China

Sponsors and Collaborators

  • Second Affiliated Hospital of Wenzhou Medical University

Investigators

  • Study Chair: Huacheng Liu, Second Affiliated Hospital of Wenzhou Medical University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Second Affiliated Hospital of Wenzhou Medical University
ClinicalTrials.gov Identifier:
NCT04720963
Other Study ID Numbers:
  • SAHoWMU-CR2020-03-114
First Posted:
Jan 22, 2021
Last Update Posted:
Jan 26, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Second Affiliated Hospital of Wenzhou Medical University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 26, 2022